awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27851660-31467F81-3171-4E99-9572-A44ADC5F9824
Q27851660-31467F81-3171-4E99-9572-A44ADC5F9824
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851660-31467F81-3171-4E99-9572-A44ADC5F9824
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors.
P2860
Q27851660-31467F81-3171-4E99-9572-A44ADC5F9824
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851660-31467F81-3171-4E99-9572-A44ADC5F9824
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
52ca73f541824b68dae7ed0dc0838bfd3b7c41c4
P2860
Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.